Conversations about #menopause are taking center stage–in work conversations, during news segments and even on Capitol Hill. Ensuring these conversations remain at the forefront has always been part of our mission. We’re committed to serving women’s health needs at all stages of her life journey. Read below to understand why recent efforts to bring menopause into the spotlight matters: 📣💬Increasing Awareness Conversations around menopause can help normalize the condition and women’s experiences, making it easier for women to share what they’re going through and talk to their OB/GYN about what comes next. 🔬📖Funding Research Recent pushes for legislation call for money to go toward research and education around menopause, specifically for clinical trials, public health and medical research. One proposed bill, Advancing Menopause Care and Mid-Life Women's Health Act, aims to help improve menopause detection and diagnosis, improve HCP training resources for treating menopause, and raise public awareness around it. 💪👭Empowering Women We know menopause is a normal part of aging, however it is often stigmatized as women struggle to talk about it. By bringing menopause into the spotlight, we honor women in their life journey —ensuring she can get the respect, understanding and care she deserves. Shout out to the women who are sharing their lived experiences loud and proud to help change the conversation and break the taboo when it comes to women’s health conditions like menopause. #WomensHealth
Organon
Pharmaceutical Manufacturing
Jersey City, NJ 130,658 followers
Here for her health
About us
Organon is a global healthcare company with a portfolio of therapies and products in women’s health, biosimilars, and established medicines across a wide array of conditions and diseases. Our mission is to deliver impactful medicines and solutions for a healthier every day. This site is intended for residents of the United States and its territories. You are reminded to protect yourself against recruiting fraud from individuals, organizations or other entities claiming to represent Organon. All official Organon recruitment emails will come from accounts formatted as [email protected] or [email protected], and Organon will never conduct interviews by chat or email, or make job offers through social media or online forums. All candidates for roles at Organon will first meet with a recruiter and interview team, via Teams or in person. Organon will never ask you to make financial transactions on its behalf or ask you to receive or ship packages or goods. For more information on adverse event reporting, visit http://bit.ly/AEReporting. To read our community guidelines, visit http://bit.ly/OrganonCommunityGuidelines. Follow us on Twitter at Organon (@OrganonLLC). Follow us on Instagram at Organon (@OrganonLLC).
- Website
-
http://www.organon.com
External link for Organon
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Jersey City, NJ
- Type
- Public Company
- Specialties
- Pharmaceutical
Locations
-
Primary
30 Hudson Street
Jersey City, NJ 07302, US
Employees at Organon
-
Flavio Meirelles
-
Isabel Pereira Pombriego
M&A | HR Projects | Executive Compensation | Compensation and Benefits strategy | Global Mobility | Proven experience in HR M&A and projects…
-
Akin Emir
-
Geoff Webb
Global Talent Brand Leader | DEI Advocate | Storyteller | Driving Future Talent Strategies | Organon
Updates
-
Preterm birth, occurring before 37 weeks of pregnancy, affects millions of families worldwide. Early intervention and specialized care are often needed. Enhancing access to quality care and investing in research and innovations to support maternal health may make a significant difference, potentially reducing the incidence of preterm birth. Together with like-minded partners and innovators, we’re committed to helping ensure healthier futures for mothers and their babies. #PretermBirth #MaternalHealth #PrenatalCare #NeonatalNurses #PrematureBabies
-
#Psoriasis affects over 7.5 million Americans aged 20 years or older, and 125 million people worldwide. Psoriasis patients may be at increased risk of cardiovascular disease, diabetes, and depression. For optimal patient care, it is essential that various healthcare professionals engage in collaborative decision-making to help ensure comprehensive care, timely treatment, and better management of both psoriasis and its associated conditions. #PsoriasisActionMonth #PsoriasisAwarenessMonth #PsoriasisAwareness #Dermatology #Rheumatology
-
At Organon, we believe a healthy pregnancy and childbirth are cornerstones of women’s health. Yet, significant barriers exist to necessary maternal health services in maternity care deserts. Dr. Charlotte Owens, MD, FACOG, Head of Medical Affairs & Outcomes Research at Organon & an OB/GYN, recently spoke with Pharmaceutical Executive to shed light on the individual and broader impacts of a lack of investment in high-quality maternal care. Read below for a few key takeaways from the conversation: 🤰 𝗧𝗵𝗲𝗿𝗲’𝘀 𝗮 𝗺𝗮𝘁𝗲𝗿𝗻𝗮𝗹 𝗰𝗮𝗿𝗲 𝗰𝗿𝗶𝘀𝗶𝘀 𝘁𝗵𝗮𝘁 𝗺𝘂𝘀𝘁 𝗯𝗲 𝘂𝗿𝗴𝗲𝗻𝘁𝗹𝘆 𝗮𝗱𝗱𝗿𝗲𝘀𝘀𝗲𝗱. Birth complications remain a significant challenge for women in the U.S. and globally, which may be due in part to a lack of access in areas where hospitals and birthing centers do not have the proper obstetric care. 👩 👨 👵 𝗧𝗵𝗲 𝗶𝗺𝗽𝗮𝗰𝘁 𝗼𝗳 𝗽𝗼𝗼𝗿 𝗺𝗮𝘁𝗲𝗿𝗻𝗮𝗹 𝗰𝗮𝗿𝗲 𝗶𝘀 𝗳𝗮𝗿-𝗿𝗲𝗮𝗰𝗵𝗶𝗻𝗴 𝗮𝗻𝗱 𝗰𝗮𝗻 𝗶𝗺𝗽𝗮𝗰𝘁 𝘄𝗼𝗺𝗲𝗻, 𝗳𝗮𝗺𝗶𝗹𝗶𝗲𝘀 𝗮𝗻𝗱 𝘀𝗼𝗰𝗶𝗲𝘁𝗶𝗲𝘀 𝗳𝗼𝗿 𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗰𝗼𝗺𝗲. Adverse outcomes for mothers extend beyond women and can have lasting social and economic effects on families and communities. 🤝 𝗔𝗱𝗱𝗿𝗲𝘀𝘀𝗶𝗻𝗴 𝗴𝗮𝗽𝘀 𝗶𝗻 𝘄𝗼𝗺𝗲𝗻’𝘀 𝗵𝗲𝗮𝗹𝘁𝗵 𝘄𝗶𝗹𝗹 𝗿𝗲𝗾𝘂𝗶𝗿𝗲 𝗮 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰, 𝗰𝗿𝗼𝘀𝘀-𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝘃𝗲 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵 𝘁𝗼 𝗮𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗲 𝗹𝗼𝗻𝗴 𝗼𝘃𝗲𝗿𝗱𝘂𝗲 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀. Organon is partnering with organizations and governments globally to help reduce the gaps in women’s health needs, including in maternal health, and to support research, funding and community action. #GenderEquity #WomensHealth
-
Despite postpartum hemorrhage (PPH) being one of the most common complications during childbirth, there has been little progress in the space. By investing in potential solutions to fill critical gaps in care, together with the global community, we can help shift the status quo so that every woman can access the best possible maternal care. #PPH #Postpartumhemorrhage #WomensHealth #MaternalHealth
-
Feelings of anxiety or fear can be common amongst women when they visit an OB/GYN, whether it’s their first-time or an annual check-up. Having open, direct conversations may help them feel supported so they can get the care they need. #WomensHealth #OBGYN
-
#Biosimilars compete with high-cost specialty brand biologics, which represent only 2% of all prescriptions but account for more than half of all pharmaceutical spending. Despite their potential cost-savings, biosimilar adoption has been slow. To learn how biosimilars aim to enhance patient access and affordability of treatment options, visit: https://ogn.llc/6041lio4l #OrganonBiosimilars #Dermatologists #Oncologists #Immunologists #Rheumatologists #Gastroenterologists #Opthamologists
-
-
Approximately 60% of teenagers have had sex by age 19, according to the Centers for Disease Control and Prevention. Some parents may feel uncomfortable initiating a conversation on sexual and reproductive health with their teens, but it can be just as important as a conversation with a healthcare professional. Having an open dialogue on topics like #contraception is a good way to empower young men and women to make informed decisions about their health. For resources to help parents with talking to teens about sex-related topics, visit: https://ogn.llc/6043l9Fut #SexualHealth #ReproductiveHealth
-
The playing field is level for the first time in the history of the games—with an equal number of male and female athletes competing. This investment in women’s sports must be met with equal investment in women’s health, so female athletes can prioritize their health, perform at their best and pursue their dreams. 🏅 #WomensHealth #WomenInSport
-
#Biosimilars have the prospect of making health care more affordable, offering the same benefits as originator biologics while potentially saving billions in taxpayer dollars. At Organon, we’re dedicated to enhancing patient access to these potentially more affordable medications.
#Biosimilars are key to lowering drug costs and saving billions in taxpayer dollars every year. Read our solutions to help patients access lower-cost medicines here: https://lnkd.in/gU8_9RgB
-